What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?

被引:73
作者
Campbell, Grant R. [2 ]
Loret, Erwann P. [1 ]
机构
[1] Univ Mediterranee, Unite Mixte Rech, INSERM, Fac Pharm,U911, F-13385 Marseille, France
[2] Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; CELLULAR IMMUNE-RESPONSES; FIBROBLAST-GROWTH-FACTOR; BLOOD-BRAIN-BARRIER; SUBTYPE-C; T-CELLS; INDUCE APOPTOSIS; DISEASE PROGRESSION; HOMONUCLEAR H-1-NMR; CIRCULAR-DICHROISM;
D O I
10.1186/1742-4690-6-50
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human immunodeficiency virus type 1 (HIV-1) trans-activator of transcription protein Tat is an important factor in viral pathogenesis. In addition to its function as the key trans-activator of viral transcription, Tat is also secreted by the infected cell and taken up by neighboring cells where it has an effect both on infected and uninfected cells. In this review we will focus on the relationship between the structure of the Tat protein and its function as a secreted factor. To this end we will summarize some of the exogenous functions of Tat that have been implicated in HIV-1 pathogenesis and the impact of structural variations and viral subtype variants of Tat on those functions. Finally, since in some patients the presence of Tat-specific antibodies or CTL frequencies are associated with slow or non-progression to AIDS, we will also discuss the role of Tat as a potential vaccine candidate, the advances made in this field, and the importance of using a Tat protein capable of eliciting a protective or therapeutic immune response to viral challenge.
引用
收藏
页数:13
相关论文
共 124 条
[1]   The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals [J].
Addo, MM ;
Altfeld, M ;
Rosenberg, ES ;
Eldridge, RL ;
Philips, MN ;
Habeeb, K ;
Khatri, A ;
Brander, C ;
Robbins, GK ;
Mazzara, GP ;
Goulder, PJR ;
Walker, BD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :1781-1786
[2]   HIV-1 Tat protein mimicry of chemokines [J].
Albini, A ;
Ferrini, S ;
Benelli, R ;
Sforzini, S ;
Giunciuglio, D ;
Aluigi, MG ;
Proudfoot, AEI ;
Alouani, S ;
Wells, TNC ;
Mariani, G ;
Rabin, RL ;
Farber, JM ;
Noonan, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) :13153-13158
[3]   Characterization of CD8+ T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya [J].
Alimonti, Judie B. ;
Kimani, Joshua ;
Matu, Lucy ;
Wachihi, Charles ;
Kaul, Rupert ;
Plummer, Francis A. ;
Fowke, Keith R. .
IMMUNOLOGY AND CELL BIOLOGY, 2006, 84 (05) :482-485
[4]   Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication [J].
Allen, TM ;
Mortara, L ;
Mothé, BR ;
Liebl, M ;
Jing, PC ;
Calore, B ;
Piekarczyk, M ;
Ruddersdorf, R ;
O'Connor, DH ;
Wang, X ;
Wang, CX ;
Allison, DB ;
Altman, JD ;
Sette, A ;
Desrosiers, RC ;
Sutter, G ;
Watkins, DI .
JOURNAL OF VIROLOGY, 2002, 76 (08) :4108-4112
[5]  
AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102
[6]  
Aries SP, 1995, J MOL MED-JMM, V73, P591
[7]   Permeability of the blood-brain barrier to HIV-1 Tat [J].
Banks, WA ;
Robinson, SM ;
Nath, A .
EXPERIMENTAL NEUROLOGY, 2005, 193 (01) :218-227
[8]  
Barillari G, 1999, BLOOD, V94, P663
[9]   THE TAT PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, A GROWTH-FACTOR FOR AIDS KAPOSI-SARCOMA AND CYTOKINE-ACTIVATED VASCULAR CELLS, INDUCES ADHESION OF THE SAME CELL-TYPES BY USING INTEGRIN RECEPTORS RECOGNIZING THE RGD AMINO-ACID-SEQUENCE [J].
BARILLARI, G ;
GENDELMAN, R ;
GALLO, RC ;
ENSOLI, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7941-7945
[10]  
Barillari G, 1999, J IMMUNOL, V163, P1929